Pheton Holdings Ltd Class A Ordinary Shares (PTHL) Stock Price, News & Analysis

Company Overview

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

Key Stats

• Today's Range: $4.30 to $4.48
• 50-Day Range: $2.16 to $4.79
• 52-Week Range: $1.32 to $6.45
• Volume: 250,358 shs
• Average Volume: 137,600 shs
• Market Capitalization: $28.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PTHL Stock Analysis - Frequently Asked Questions

How have PTHL shares performed this year?

Pheton Holdings Ltd Class A Ordinary Shares' stock was trading at $4.41 at the beginning of 2025. Since then, PTHL stock has decreased by 0.5% and is now trading at $4.39.
View the best growth stocks for 2025 here.

When did Pheton Holdings Ltd Class A Ordinary Shares IPO?

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) raised $11 million in an initial public offering on Thursday, September 5th 2024. The company issued 2,500,000 shares at $4.00-$5.00 per share. Cathay Securities served as the underwriter for the IPO.

How do I buy shares of Pheton Holdings Ltd Class A Ordinary Shares?

Shares of PTHL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Pheton Holdings Ltd Class A Ordinary Shares own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Pheton Holdings Ltd Class A Ordinary Shares investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

• Today: 5/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:PTHL
• CIK: 1970544
• Web: www.ftzy.com.cn
• Phone: 86-10-8481-7665
• Fax: N/A
• Employees: 11
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $448,196.00
• Price / Sales: 64.47
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 6,582,000
• Free Float: N/A
• Market Cap: $28.89 million
• Optionable: N/A
• Beta: N/A